FDA Announces Recall Of Boston Scientific’s Lotus Edge TAVR System
Executive Summary
The US agency announced on 11 January a recall of the Lotus Edge transcatheter aortic valve replacement (TAVR) system – a device that Boston Scientific stopped making and voluntarily recalled two months ago.